Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

NASDAQ:LNTH

Overview | Financials
Company Name Lantheus Holdings, Inc.
Symbol LNTH
Currency USD
Price 101.98
Market Cap 7,080,532,588
Dividend Yield 0%
52-week-range 50.2 - 126.89
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Mary Anne Heino
Website https://www.lantheus.com

An error occurred while fetching data.

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to

Related Stocks

Premier, Inc. logo

Premier, Inc.

PINC

20.44 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

335.74 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

149.05 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

41.05 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

42.4 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

162.32 USD

Alkermes plc logo

Alkermes plc

ALKS

26.86 USD

Evotec SE logo

Evotec SE

EVO

8.69 USD

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

43.45 USD

Financials

Numbers are in millions USD

Numbers are in millions USD